- Drug Regimen
- The Efficacy and Safety of Moderate-Intensity Rosuvastatin with Ezetimibe versus High-Intensity Rosuvastatin in High Atherosclerotic Cardiovascular Disease Risk Patients with Type 2 Diabetes Mellitus: A Randomized, Multicenter, Open, Parallel, Phase 4 Study
-
Jun Sung Moon, Il Rae Park, Sang Soo Kim, Hye Soon Kim, Nam Hoon Kim, Sin Gon Kim, Seung Hyun Ko, Ji Hyun Lee, Inkyu Lee, Bo Kyeong Lee, Kyu Chang Won
-
Diabetes Metab J. 2023;47(6):818-825. Published online November 24, 2023
-
DOI: https://doi.org/10.4093/dmj.2023.0171
-
-
5,795
View
-
446
Download
-
4
Web of Science
-
5
Crossref
-
Abstract
PDF Supplementary Material PubReader ePub
- Background
To investigate the efficacy and safety of moderate-intensity rosuvastatin/ezetimibe combination compared to highintensity rosuvastatin in high atherosclerotic cardiovascular disease (ASCVD) risk patients with type 2 diabetes mellitus (T2DM).
Methods This study was a randomized, multicenter, open, parallel phase 4 study, and enrolled T2DM subjects with an estimated 10-year ASCVD risk ≥7.5%. The primary endpoint was the low-density lipoprotein cholesterol (LDL-C) change rate after 24-week rosuvastatin 10 mg/ezetimibe 10 mg treatment was non-inferior to that of rosuvastatin 20 mg. The achievement proportion of 10-year ASCVD risk <7.5% or comprehensive lipid target (LDL-C <70 mg/dL, non-high-density lipoprotein cholesterol <100 mg/dL, and apolipoprotein B <80 mg/dL) without discontinuation, and several metabolic parameters were explored as secondary endpoints.
Results A hundred and six participants were assigned to each group. Both groups showed significant reduction in % change of LDL-C from baseline at week 24 (–63.90±6.89 vs. –55.44±6.85, combination vs. monotherapy, p=0.0378; respectively), but the combination treatment was superior to high-intensity monotherapy in LDL-C change (%) from baseline (least square [LS] mean difference, –8.47; 95% confidence interval, –16.44 to –0.49; p=0.0378). The combination treatment showed a higher proportion of achieved comprehensive lipid targets rather than monotherapy (85.36% vs. 62.22% in monotherapy, p=0.015). The ezetimibe combination significantly improved homeostasis model assessment of β-cell function even without A1c changes (LS mean difference, 17.13; p=0.0185).
Conclusion In high ASCVD risk patients with T2DM, the combination of moderate-intensity rosuvastatin and ezetimibe was not only non-inferior but also superior to improving dyslipidemia with additional benefits compared to high-intensity rosuvastatin monotherapy.
-
Citations
Citations to this article as recorded by 
- Clinical study on the effect of jejunoileal side-to-side anastomosis on metabolic parameters in patients with type 2 diabetes
Ji-Kui Wang, Di Zhang, Jin-Feng Wang, Wan-Lin Lu, Jing-Yuan Wang, Shi-Feng Liang, Ran Liu, Jing-Xin Jiang, Hong-Tao Li, Xuan Yang World Journal of Diabetes.2025;[Epub] CrossRef - Overcoming β-Cell Dysfunction in Type 2 Diabetes Mellitus: CD36 Inhibition and Antioxidant System
Il Rae Park, Yong Geun Chung, Kyu Chang Won Diabetes & Metabolism Journal.2025; 49(1): 1. CrossRef - Does Rosuvastatin/Ezetimibe Combination Therapy Offer Potential Benefits for Glucose Metabolism beyond Lipid-Lowering Efficacy in T2DM?
Il Rae Park, Jun Sung Moon Diabetes & Metabolism Journal.2024; 48(3): 387. CrossRef - Efficacy and safety of double-dose statin monotherapy versus moderate-intensity statin combined with ezetimibe dual therapy in diabetic patients: a systematic review and meta-analysis of randomized controlled trials
Aman Goyal, Muhammad Daoud Tariq, Hritvik Jain, Abhigan Babu Shrestha, Laveeza Fatima, Romana Riyaz, Hritik Raj Yadav, Darsh Safi, Abdul Qahar K. Yasinzai, Rozi Khan, Amir Humza Sohail, Mohamed Daoud, Abu Baker Sheikh Cardiovascular Endocrinology & Metabolism.2024;[Epub] CrossRef - Efficacy and safety of moderate-intensity rosuvastatin plus ezetimibe versus high-intensity rosuvastatin monotherapy in the treatment of composite cardiovascular events with hypercholesterolemia: A meta-analysis
Lingyan Liu, Yongkun Deng, Lei Li, Xingbiao Yang, Zhaoheng Yin, Yong Lai, Jaspinder Kaur PLOS ONE.2024; 19(11): e0310696. CrossRef
- Basic Research
-
- The Effects of Exercise and Restriction of Sugar-Sweetened Beverages on Muscle Function and Autophagy Regulation in High-Fat High-Sucrose-Fed Obesity Mice
-
Didi Zhang, Ji Hyun Lee, Hyung Eun Shin, Seong Eun Kwak, Jun Hyun Bae, Liang Tang, Wook Song
-
Diabetes Metab J. 2021;45(5):773-786. Published online March 25, 2021
-
DOI: https://doi.org/10.4093/dmj.2020.0157
-
-
8,723
View
-
270
Download
-
6
Web of Science
-
6
Crossref
-
Graphical Abstract
Abstract
PDF Supplementary Material PubReader ePub

- Background
Autophagy maintains muscle mass and healthy skeletal muscles. Several recent studies have associated sugar-sweetened beverage (SSB) consumption with diseases. We investigated whether muscle dysfunction due to obesity could be restored by SSB restriction (SR) alone or in combination with exercise (EX) training.
Methods Obese mice were subjected to SR combined with treadmill EX. Intraperitoneal glucose tolerance test, grip strength test, hanging time test, and body composition analysis were performed. Triglyceride (TG) and total cholesterol (TC) serum concentrations and TG concentrations in quadriceps muscles were analyzed. Western blot and reverse transcription-quantitative polymerase chain reaction helped analyze autophagy-related protein and mRNA expression, respectively.
Results SR alone had no significant effect on fasting blood glucose levels, glucose tolerance, and muscle function. However, it had effect on serum TC, serum TG, and BCL2 interacting protein 3 expression. SR+EX improved glucose tolerance and muscle function and increased serum TC utilization than SR alone. SR+EX reduced P62 levels, increased glucose transporter type 4 and peroxisome proliferator-activated receptor γ coactivator-1α protein expression, and improved grip strength relative to the high-fat and high-sucrose liquid (HFHS) group, and this was not observed in the HFHS+EX group.
Conclusion SR induced mitophagy-related protein expression in quadriceps, without affecting muscle function. And, the combination of SR and EX activated mitophagy-related proteins and improved muscle function.
-
Citations
Citations to this article as recorded by 
- Mitochondrial Dysfunction, Oxidative Stress, and Inter-Organ Miscommunications in T2D Progression
Rajakrishnan Veluthakal, Diana Esparza, Joseph M. Hoolachan, Rekha Balakrishnan, Miwon Ahn, Eunjin Oh, Chathurani S. Jayasena, Debbie C. Thurmond International Journal of Molecular Sciences.2024; 25(3): 1504. CrossRef - The association between healthy beverage index and sarcopenia in Iranian older adults: a case-control study
Marzieh Mahmoodi, Zainab Shateri, Mehran Nouri, Mohebat Vali, Nasrin Nasimi, Zahra Sohrabi, Mohammad Hossein Dabbaghmanesh, Maede Makhtoomi BMC Geriatrics.2024;[Epub] CrossRef - Interplay of skeletal muscle and adipose tissue: sarcopenic obesity
Min Jeong Park, Kyung Mook Choi Metabolism.2023; 144: 155577. CrossRef - Association between sugar-sweetened beverage consumption frequency and muscle strength: results from a sample of Chinese adolescents
Yunjie Zhang, Pan Xu, Yongjing Song, Nan Ma, Jinkui Lu BMC Public Health.2023;[Epub] CrossRef - Muscle strength and prediabetes progression and regression in middle‐aged and older adults: a prospective cohort study
Shanhu Qiu, Xue Cai, Yang Yuan, Bo Xie, Zilin Sun, Duolao Wang, Tongzhi Wu Journal of Cachexia, Sarcopenia and Muscle.2022; 13(2): 909. CrossRef - INTENSITY OF FREE RADICAL PROCESSES IN RAT SKELETAL MUSCLES UNDER THE CONDITIONS OF DIFFERENT DIETARY SUPPLY WITH NUTRIENTS
O.M. Voloshchuk, Н.P. Kopylchuk Fiziolohichnyĭ zhurnal.2022; 68(4): 48. CrossRef
- Response: Adipokines and Insulin Resistance According to Characteristics of Pregnant Women with Gestational Diabetes Mellitus (Diabetes Metab J 2017;41:457-65)
-
Eon Ju Jeon, Ji Hyun Lee
-
Diabetes Metab J. 2018;42(1):90-91. Published online February 23, 2018
-
DOI: https://doi.org/10.4093/dmj.2018.42.1.90
-
-
3,989
View
-
36
Download
-
3
Web of Science
-
1
Crossref
-
PDF PubReader
-
Citations
Citations to this article as recorded by 
- Effects of miR-152-Mediated Targeting of SOCS3 on Hepatic Insulin Resistance in Gestational Diabetes Mellitus Mice
Yuanchun Li, Li Kang, Juanjuan Huang, Juan Zhang, Chunhua Liu, Wenjuan Shen The American Journal of the Medical Sciences.2021; 361(3): 365. CrossRef
- Clinical Diabetes & Therapeutics
- Adipokines and Insulin Resistance According to Characteristics of Pregnant Women with Gestational Diabetes Mellitus
-
Eon Ju Jeon, Seong Yeon Hong, Ji Hyun Lee
-
Diabetes Metab J. 2017;41(6):457-465. Published online November 15, 2017
-
DOI: https://doi.org/10.4093/dmj.2017.41.6.457
-
-
4,856
View
-
45
Download
-
15
Web of Science
-
15
Crossref
-
Abstract
PDF PubReader
- Background
The aim of this study was to evaluate adipokines concentration and insulin resistance according to maternal age or obesity at pregnancy and weight change at diagnosed gestational diabetes mellitus (GDM) in pregnant women with GDM. MethodsThis study included 57 pregnant women who were diagnosed with GDM at 24 to 28 weeks of gestation. The subjects were classified into two or three groups according to pre-pregnancy body mass index (BMI, <25 kg/m2 vs. ≥25 kg/m2), maternal age at pregnancy (<35 years old vs. ≥35 years old), and weight change during pregnancy at screening for GDM (weight change below, within, and in excess of the recommended range). They were respectively compared in each group. ResultsLeptin, homeostasis model assessment of insulin resistance (HOMA-IR), and HOMA2-%B were increased in the group with pre-pregnancy BMI ≥25 kg/m2. Leptin and HOMA-IR were positively correlated with BMI both before pregnancy and at screening for GDM. There were no significant correlations between HOMA-IR and adipokines. HOMA-IR showed positive correlation with HOMA2-%B and negative correlation with HOMA2-%S. ConclusionLeptin and HOMA-IR at diagnosed GDM were increased in the GDM patients with obesity before pregnancy. They were positively correlated with BMI both before pregnancy and at screening for GDM. The effect of maternal age at pregnancy and weight change during pregnancy at GDM screening on adipokines and insulin resistance might be less pronounced than the effect of maternal obesity.
-
Citations
Citations to this article as recorded by 
- L-ergothioneine reduces mitochondrial-driven NLRP3 activation in gestational diabetes mellitus
Colm J. McElwain, Andrea Musumeci, Samprikta Manna, Fergus P. McCarthy, Cathal M. McCarthy Journal of Reproductive Immunology.2024; 161: 104171. CrossRef - Serum progesterone, glycosylated hemoglobin and insulin levels with the risk of premature rupture of membranes in gestational diabetes mellitus
LiRong Zhou, XueSong Xiong, LianHua Chen Clinics.2024; 79: 100461. CrossRef - Association of the comorbidity of gestational diabetes mellitus and hypertension disorders of pregnancy with birth outcomes
Xingxi Lin, Luhan Zhou, Shuting Si, Haoyue Cheng, Xialidan Alifu, Yiwen Qiu, Yan Zhuang, Ye Huang, Libi Zhang, Diliyaer Ainiwan, Hui Liu, Yunxian Yu Frontiers in Endocrinology.2024;[Epub] CrossRef - The therapeutic effects of attending a one-day outpatient service on patients with gestational diabetes and different pre-pregnancy body mass indices
Yan-Min Cao, Min Ma, Wei Wang, Na-Na Cai Frontiers in Public Health.2023;[Epub] CrossRef - Insulin Resistance in Gestational Diabetes Mellitus and Its Association With Anthropometric Fetal Indices
Tuan Dinh Le, Tien Minh Bui, Trinh Hien Vu, Nga Phi Thi Nguyen, Hoa Thanh Thi Tran, Son Tien Nguyen, Lan Ho Thi Nguyen, Manh Van Ngo, Hoang Huy Duong, Binh Thanh Vu, Hoa Trung Dinh, Binh Nhu Do, Duc-Cuong Le, Hien Thi Nguyen, Kien Trung Nguyen Clinical Medicine Insights: Endocrinology and Diabetes.2022;[Epub] CrossRef - New Insights into Adipokines in Gestational Diabetes Mellitus
Jorge Valencia-Ortega, Rebeca González-Reynoso, Edgar G. Ramos-Martínez, Aldo Ferreira-Hermosillo, María I. Peña-Cano, Enrique Morales-Ávila, Renata Saucedo International Journal of Molecular Sciences.2022; 23(11): 6279. CrossRef - The combination from ethanol extract of moringa leaves (Moringa oleifera L.) and ethanol extract of papaya leaves (Carica papaya L.) slows the tumor growth in sprague dawley rats induced 7,12-dimethylbenz(a)anthracene
Mutmainah Arif, Ika Yustisia, Padlianah Medicina Clínica Práctica.2020; 3: 100100. CrossRef - Insulin resistance (IR) in pregnant women at the Mother and Child Hospital Khadijah, Makassar, Indonesia
Hasbobi Tabrang, Elizabet C. Jusuf, Himawan Sanusi Enfermería Clínica.2020; 30: 84. CrossRef - Vitamin D Deficiency at Mid-Pregnancy Is Associated with a Higher Risk of Postpartum Glucose Intolerance in Women with Gestational Diabetes Mellitus
Kyung-Soo Kim, Seok Won Park, Yong-Wook Cho, Soo-Kyung Kim Endocrinology and Metabolism.2020; 35(1): 97. CrossRef - Involvement of the Endocrine-Disrupting Chemical Bisphenol A (BPA) in Human Placentation
Sophie-Christine de Aguiar Greca, Ioannis Kyrou, Ryan Pink, Harpal Randeva, Dimitris Grammatopoulos, Elisabete Silva, Emmanouil Karteris Journal of Clinical Medicine.2020; 9(2): 405. CrossRef - Joint Associations of Maternal Gestational Diabetes and Hypertensive Disorders of Pregnancy With Overweight in Offspring
Yuying Gu, Jun Lu, Weiqin Li, Huikun Liu, Leishen Wang, Junhong Leng, Wei Li, Shuang Zhang, Shuting Wang, Jaakko Tuomilehto, Zhijie Yu, Xilin Yang, Andrea A. Baccarelli, Lifang Hou, Gang Hu Frontiers in Endocrinology.2019;[Epub] CrossRef - Reduced Serum Adiponectin Level and Risk of Poststroke Depression in Patients with Ischemic Stroke
Junhua Yang, Guanghui Du, Jinyu Wang, Jia Chen, Chenghui Yang, Jia Li, Yun Zhang Journal of Stroke and Cerebrovascular Diseases.2019; 28(2): 305. CrossRef - Letter: Adipokines and Insulin Resistance According to Characteristics of Pregnant Women with Gestational Diabetes Mellitus (Diabetes Metab J 2017;41:457-65)
Ohk-Hyun Ryu Diabetes & Metabolism Journal.2018; 42(1): 87. CrossRef - The importance of treating mild hyperglycemia in pregnant women with diabetes
Kyung-Soo Kim The Korean Journal of Internal Medicine.2018; 33(6): 1079. CrossRef - Response: Adipokines and Insulin Resistance According to Characteristics of Pregnant Women with Gestational Diabetes Mellitus (Diabetes Metab J 2017;41:457-65)
Eon Ju Jeon, Ji Hyun Lee Diabetes & Metabolism Journal.2018; 42(1): 90. CrossRef
- Others
- Cystatin C as a Predictor for Diabetes according to Glycosylated Hemoglobin Levels in Korean Patients
-
Eon Ju Jeon, Ji Hyun Lee
-
Diabetes Metab J. 2016;40(1):32-34. Published online February 19, 2016
-
DOI: https://doi.org/10.4093/dmj.2016.40.1.32
-
-
3,653
View
-
42
Download
-
1
Web of Science
-
2
Crossref
-
PDF PubReader
-
Citations
Citations to this article as recorded by 
- Prognostic significance of serum cystatin C in acute brainstem infarctions patients
H. Li, B. Zhang, Z. Huang, H. Wu, B. Qin, L. Zhou, Z. Lu, F. Qin Revue Neurologique.2024; 180(7): 642. CrossRef - To compare the level of cystatin C in type 2 diabetes mellitus with obesity
Chahat Jhatta, Jashan Girdhar, Sumeet Gupta, Inderjeet Verma Indian Journal of Endocrinology and Metabolism.2020; 24(4): 312. CrossRef
|